SCHEMBL6711883

SCHEMBL6711883

Cc1cccc(CC(=O)Nc2cccc3cc(C(=O)Nc4ccc(Cl)cc4-c4noc(=O)[nH]4)[nH]c23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2B Q14289 1/20 0.39
GRIK1 P39086 1/20 0.39
P2RY14 Q15391 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CSNK1D P48730 1/20 0.38
PLCG2 P16885 1/20 0.37
KCNQ2 O43526 2/20 0.36
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708770 0.94 GRIK1 (0.41) PTK2BGRIK1P2RY14MEN1ALDH1A1
SCHEMBL6707991 0.93 PTK2B (0.41) PTK2BGRIK1P2RY14KDM4EMEN1
SCHEMBL6709861 0.92 GRIK1 (0.41) GRIK1KDM4EMEN1ALDH1A1TP53
SCHEMBL6713394 0.91 PARP14 (0.42) GRIK1KDM4EMEN1ALDH1A1TP53
SCHEMBL6711931 0.91 L3MBTL1 (0.38) PTK2BGRIK1MEN1KMT2AL3MBTL1
SCHEMBL6707881 0.91 PARP14 (0.42) GRIK1MEN1TP53KMT2AL3MBTL1
SCHEMBL6708743 0.90 POLB (0.45) GRIK1P2RY14MEN1ALDH1A1TP53
SCHEMBL6707625 0.90 GSK3A (0.41) GRIK1MEN1KMT2APLCG2LMNA
SCHEMBL6711895 0.90 PARP14 (0.44) GRIK1KDM4EMEN1TP53KMT2A
SCHEMBL6918285 0.89 PARP14 (0.42) GRIK1KDM4EMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PTK2B 4069/4885GRIK1 3885/4885P2RY14 2088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.